RCN1 was linked to cancer progression and its downregulation significantly suppresses PCa cell viability and arrests the cell cycles of DU145 and LNCaP cells, highlighting its potential as a therapeutic target in cancer treatment [81]. Here, RCN1 is linked to posterior cortical atrophy.